Ibuprofen Patent Expiration

Ibuprofen was first introduced by Mcneil Consumer Healthcare Div Mcneil Ppc Inc in its drug Motrin on Approved Prior to Jan 1, 1982. Other drugs containing Ibuprofen are Children'S Advil-Flavored, Rufen, Motrin Ib, Advil, Advil Liqui-Gels, Motrin Migraine Pain, Midol Liquid Gels, Infant'S Advil, Pediatric Advil, Children'S Advil, Nuprin, Advil Migraine Liqui-Gels, Junior Strength Advil, Children'S Motrin, Children'S Elixsure, Caldolor, Ibu, Junior Strength Motrin. 71 different companies have introduced drugs containing Ibuprofen.


Ibuprofen Patents

Given below is the list of patents protecting Ibuprofen, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Caldolor US11806400 Injectable ibuprofen formulation Mar 16, 2032 Cumberland Pharms
Caldolor US9072661 Injectable ibuprofen formulation Mar 16, 2032 Cumberland Pharms
Caldolor US9072710 Injectable ibuprofen formulation Mar 16, 2032 Cumberland Pharms
Caldolor US9012508 Administration of intravenous ibuprofen Sep 14, 2030 Cumberland Pharms
Caldolor US8735452 Treating patients with intravenous ibuprofen Sep 30, 2029 Cumberland Pharms
Caldolor US8871810 Treating critically ill patients with intravenous ibuprofen Sep 30, 2029 Cumberland Pharms
Caldolor US9114068 Treating patients with intravenous ibuprofen Sep 30, 2029 Cumberland Pharms
Caldolor US9138404 Treating critically ill patients with intravenous ibuprofen Sep 30, 2029 Cumberland Pharms
Caldolor US9295639 Treating critically ill patients with intravenous ibuprofen Sep 30, 2029 Cumberland Pharms
Caldolor US9649284 Treating critically ill patients with intravenous ibuprofen Sep 30, 2029 Cumberland Pharms
Children's Advil-flavored US10238640 Pharmaceutical suspension composition May 25, 2024

(Expired)

Haleon Us Holdings
Caldolor US6727286 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid Nov 27, 2021

(Expired)

Cumberland Pharms
Midol Liquid Gels US6251426 Ibuprofen-containing softgels Jun 25, 2018

(Expired)

Bionpharma



Ibuprofen's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ibuprofen Generic API Manufacturers

Several generic applications have been filed for Ibuprofen. The first generic version for Ibuprofen was by Basf Corp and was approved on Feb 8, 1985. And the latest generic version is by Pai Holdings Llc Dba Pharmaceutical Associates Inc and was approved on Nov 8, 2024.

Given below is the list of companies who have filed for Ibuprofen generic, along with the locations of their manufacturing plants worldwide.